Handbook of Dialysis Therapy (Sixth Edition) - Chapter 53: Care of the Human Immunodeficiency Virus–Infected End-Stage Kidney Disease Patient

Elsevier, Handbook of Dialysis Therapy (Sixth Edition), 2023, Pages 481-490
Authors: 
Luis G. Tulloch-Palomino MD, Jonathan Casavant PharmD, BCPS, Rudolph A. Rodriguez MD

The human immunodeficiency virus (HIV)–infected end-stage renal disease (ESKD) patient presents specific clinical and logistical challenges to dialysis care providers. In this chapter, we discuss the shifting epidemiology and current management of ESKD in people living with HIV.

Read on ScienceDirect
Show previous page

Category:

Book chapters

Tags:

Health and population; Health and wellbeing; Global

Related content

Neuropathology of Aging and Alzheimer's Disease: Chapter 10 - The role of vascular disease in Alzheimer’s disease neuropathology
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, Volume 1 (Seventh Edition): Chapter 7 - Pharmacogenomic approaches to the treatment of sporadic Alzheimer’s disease
Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis: Chapter 16 - FDG-PET: Tryptamine-treated mouse model and Alzheimer's disease patients. Conceptual evolution of microbiota tryptamine role in human diseases
Heavy Metal Toxicity and Neurodegeneration: Chapter 12 - Heavy metals and Alzheimer’s disease: a review
Natural Molecules in Neuroprotection and Neurotoxicity: Chapter 70 - Neuroprotection induced by terpenes: focus on Alzheimer’s disease and Parkinson’s disease